Search research articles
Contact Us
Filters
Showing results (91-100 of 124) with videos related to
Page
of 13
Sort By:
World Journal of Gastroenterology
|
September 25, 2012
Clinicopathologic significance of expression of nuclear factor-κB RelA and its target gene products in gastric cancer patients
Hyuk-Chan Kwon, Sung-Hyun Kim, Sung Yong Oh, et al.
American Journal of Hematology
|
November 26, 2002
Urokinase could increase the yield of progenitor cells during red cell depletion in elapsed and anticoagulated cord blood
Young-Ho Lee, Jin-Yeong Han, Su-Yeong Seo, et al.
American Journal of Clinical Oncology
|
September 23, 2009
A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer
Byung Geun Kim, Sung Yong Oh, Hyuk-Chan Kwon, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
March 20, 2012
Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer
Hyuk-Chan Kwon, Sung Hyun Kim, Sung Yong Oh, et al.
Investigational New Drugs
|
August 14, 2010
A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer
Sung Yong Oh, Hyuk-Chan Kwon, Sang-Ho Jeong, et al.
Cancer Research and Treatment
|
April 17, 2010
Impact of the new AJCC staging system and adjuvant treatment in rectal cancer
Shin Ae Lee, Hyuk-Chan Kwon, Min Ah Park, et al.
Investigational New Drugs
|
April 2, 2010
Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness
Sung Yong Oh, Chi Young Jeong, Soon Chan Hong, et al.
World Journal of Gastroenterology
|
March 15, 2012
Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer
Lee Chun Park, Ho Sup Lee, Seong Hoon Shin, et al.
BMC Cancer
|
May 3, 2008
Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer
Sung Yong Oh, Hyuk-Chan Kwon, Sung-Hyun Kim, et al.
Journal of Korean Medical Science
|
April 15, 2004
Autoimmune hemolytic anemia in a patient with primary ovarian non-Hodgkin's lymphoma
Chang Kil Jung, Jong Seung Park, Eun Ju Lee, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 124) with videos related to
Sort By:
Page
of 13
World Journal of Gastroenterology
|
September 25, 2012
Clinicopathologic significance of expression of nuclear factor-κB RelA and its target gene products in gastric cancer patients
Hyuk-Chan Kwon, Sung-Hyun Kim, Sung Yong Oh, et al.
American Journal of Hematology
|
November 26, 2002
Urokinase could increase the yield of progenitor cells during red cell depletion in elapsed and anticoagulated cord blood
Young-Ho Lee, Jin-Yeong Han, Su-Yeong Seo, et al.
American Journal of Clinical Oncology
|
September 23, 2009
A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer
Byung Geun Kim, Sung Yong Oh, Hyuk-Chan Kwon, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
March 20, 2012
Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer
Hyuk-Chan Kwon, Sung Hyun Kim, Sung Yong Oh, et al.
Investigational New Drugs
|
August 14, 2010
A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer
Sung Yong Oh, Hyuk-Chan Kwon, Sang-Ho Jeong, et al.
Cancer Research and Treatment
|
April 17, 2010
Impact of the new AJCC staging system and adjuvant treatment in rectal cancer
Shin Ae Lee, Hyuk-Chan Kwon, Min Ah Park, et al.
Investigational New Drugs
|
April 2, 2010
Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness
Sung Yong Oh, Chi Young Jeong, Soon Chan Hong, et al.
World Journal of Gastroenterology
|
March 15, 2012
Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer
Lee Chun Park, Ho Sup Lee, Seong Hoon Shin, et al.
BMC Cancer
|
May 3, 2008
Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer
Sung Yong Oh, Hyuk-Chan Kwon, Sung-Hyun Kim, et al.
Journal of Korean Medical Science
|
April 15, 2004
Autoimmune hemolytic anemia in a patient with primary ovarian non-Hodgkin's lymphoma
Chang Kil Jung, Jong Seung Park, Eun Ju Lee, et al.
Page
of 13